Publication | Open Access
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
485
Citations
40
References
2016
Year
Neuro-oncologyGliomaRadiation TherapyMedicineIntergroup StudyEortc 22033-26033High-grade GliomasCancer TreatmentOncologyRadiation OncologyHigh-risk Low-grade GliomaRadiologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1